15-fluoro prostaglandins as ocular hypotensives
US6680339B2 · kind B2 · utility
7Cited by
4References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 18, 2002 |
| Grant date | Jan 20, 2004 |
| Priority date | — |
| Expiry date | May 24, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/5575
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
15-fluoro substituted analogs of PGF2&agr; and methods of their use in treating glaucoma and ocular hypertension are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.